GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Cyclically Adjusted PS Ratio

Star Lake Bioscience Co (SHSE:600866) Cyclically Adjusted PS Ratio : 1.37 (As of Apr. 29, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Cyclically Adjusted PS Ratio?

As of today (2024-04-29), Star Lake Bioscience Co's current share price is ¥5.75. Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥4.19. Star Lake Bioscience Co's Cyclically Adjusted PS Ratio for today is 1.37.

The historical rank and industry rank for Star Lake Bioscience Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:600866' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.96   Med: 2.54   Max: 4.48
Current: 1.2

During the past years, Star Lake Bioscience Co's highest Cyclically Adjusted PS Ratio was 4.48. The lowest was 0.96. And the median was 2.54.

SHSE:600866's Cyclically Adjusted PS Ratio is ranked better than
82.41% of 506 companies
in the Biotechnology industry
Industry Median: 5.395 vs SHSE:600866: 1.20

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Star Lake Bioscience Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥2.528. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥4.19 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Star Lake Bioscience Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Star Lake Bioscience Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Cyclically Adjusted PS Ratio Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 3.01 3.29 1.87 1.17

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 1.55 1.38 1.17 1.03

Competitive Comparison of Star Lake Bioscience Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Star Lake Bioscience Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Cyclically Adjusted PS Ratio falls into.



Star Lake Bioscience Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Star Lake Bioscience Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.75/4.19
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Lake Bioscience Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Star Lake Bioscience Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.528/114.6694*114.6694
=2.528

Current CPI (Mar. 2024) = 114.6694.

Star Lake Bioscience Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.352 98.200 0.411
201409 0.388 98.900 0.450
201412 0.487 99.000 0.564
201503 0.353 99.900 0.405
201506 0.318 99.500 0.366
201509 0.266 100.500 0.304
201512 0.189 100.600 0.215
201603 0.240 102.200 0.269
201606 0.263 101.400 0.297
201609 0.261 102.400 0.292
201612 0.378 102.600 0.422
201703 0.175 103.200 0.194
201706 0.257 103.100 0.286
201709 0.314 104.100 0.346
201712 0.345 104.500 0.379
201803 0.359 105.300 0.391
201806 0.330 104.900 0.361
201809 0.309 106.600 0.332
201812 0.452 106.500 0.487
201903 0.426 107.700 0.454
201906 0.329 107.700 0.350
201909 0.393 109.800 0.410
201912 0.265 111.200 0.273
202003 0.388 112.300 0.396
202006 0.404 110.400 0.420
202009 0.299 111.700 0.307
202012 0.420 111.500 0.432
202103 0.411 112.662 0.418
202106 0.398 111.769 0.408
202109 0.354 112.215 0.362
202112 3.179 113.108 3.223
202203 3.643 114.335 3.654
202206 4.064 114.558 4.068
202209 3.539 115.339 3.518
202212 3.504 115.116 3.490
202303 2.504 115.116 2.494
202306 2.470 114.558 2.472
202309 2.688 115.339 2.672
202312 2.793 114.669 2.793
202403 2.528 114.669 2.528

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Star Lake Bioscience Co  (SHSE:600866) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Star Lake Bioscience Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines